About Chiral Emcure
Chiral Emcure is a company based in Pune (India) founded in 1981. It operates as a B2B and Outsourcing. The company has 6,877 employees as of March 31, 2024. Chiral Emcure offers products and services including APIs, Formulations, and Biotechnology Products. Chiral Emcure operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Pune, India
- Employees 6877 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Emcure Pharmaceuticals Limited
- Jurisdiction Pune City, Maharashtra, India
-
Annual Revenue
$784.49 M (USD)11.33as on Mar 31, 2024
-
Net Profit
$61.63 M (USD)-6.1as on Mar 31, 2024
-
EBITDA
$143.66 M (USD)4.11as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
6877
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chiral Emcure
Chiral Emcure offers a comprehensive portfolio of products and services, including APIs, Formulations, and Biotechnology Products.
Production of active pharmaceutical ingredients for drug development.
Creation of finished pharmaceutical products for various applications.
Development of biotechnology-based pharmaceuticals and solutions.
Funding Insights of Chiral Emcure
Detailed funding history for Chiral Emcure
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chiral Emcure
Investment portfolio details for Chiral Emcure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chiral Emcure
Detailed financials for Chiral Emcure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chiral Emcure Comparisons
Peer comparison for Chiral Emcure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chiral Emcure
Chiral Emcure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Chiral Emcure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chiral Emcure
Complete news archive for Chiral Emcure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chiral Emcure
Chiral Emcure was founded in 1981.
Chiral Emcure is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at Chiral Emcure is 6,877.
Annual revenue of Chiral Emcure is $784.49M as on Mar 31, 2024.
Emcure is a vertically integrated pharmaceutical company that conducts research and manufacturing of active pharmaceutical ingredients (APIs), formulations, and biotechnology products. It serves as a preferred outsourcing partner for major multinational corporations in India and international markets. Based in Pune, India, the company focuses on high-quality production and innovation, while adhering to industry standards and partnering with global entities for distribution and development.
Chiral Emcure's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Chiral Emcure offers APIs, Formulations, and Biotechnology Products.